30th Apr 2021 14:04
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 29 April 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD |
|
| ||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
1,719,156 | 1.33% | 165,887 | 0.13% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
72,359 | 0.06% | 7,134 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
1,797,615 | 1.39% | 179,121 | 0.14% | ||
|
|
|
| ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 247.9900 USD |
| Purchase | 2 | 247.0400 USD |
| Purchase | 33 | 246.0830 USD |
| Purchase | 56 | 245.1400 USD |
| Purchase | 100 | 245.0000 USD |
| Purchase | 195 | 244.5600 USD |
| Purchase | 275 | 247.6209 USD |
| Purchase | 467 | 247.5609 USD |
| Purchase | 607 | 245.5101 USD |
| Purchase | 819 | 245.7466 USD |
| Purchase | 2,125 | 248.1300 USD |
| Purchase | 3,696 | 245.9481 USD |
| Purchase | 3,962 | 246.7256 USD |
| Purchase | 4,061 | 246.6705 USD |
| Purchase | 4,119 | 245.7612 USD |
| Purchase | 4,775 | 248.1270 USD |
| Purchase | 6,956 | 246.5036 USD |
| Purchase | 27,970 | 246.3745 USD |
| Sale | 2 | 247.3400 USD |
| Sale | 3 | 248.0100 USD |
| Sale | 3 | 247.9400 USD |
| Sale | 4 | 247.1700 USD |
| Sale | 4 | 246.9650 USD |
| Sale | 4 | 247.2025 USD |
| Sale | 4 | 247.2475 USD |
| Sale | 4 | 247.6600 USD |
| Sale | 6 | 247.7233 USD |
| Sale | 8 | 247.3700 USD |
| Sale | 9 | 247.4050 USD |
| Sale | 12 | 247.5633 USD |
| Sale | 16 | 247.7212 USD |
| Sale | 16 | 245.3300 USD |
| Sale | 16 | 247.6115 USD |
| Sale | 20 | 247.4990 USD |
| Sale | 20 | 247.7800 USD |
| Sale | 21 | 245.7909 USD |
| Sale | 22 | 247.3540 USD |
| Sale | 24 | 245.3099 USD |
| Sale | 35 | 247.9500 USD |
| Sale | 50 | 245.1000 USD |
| Sale | 56 | 247.7228 USD |
| Sale | 70 | 247.9300 USD |
| Sale | 100 | 247.6000 USD |
| Sale | 100 | 246.7109 USD |
| Sale | 100 | 245.0850 USD |
| Sale | 100 | 246.9500 USD |
| Sale | 103 | 247.2501 USD |
| Sale | 130 | 244.8286 USD |
| Sale | 178 | 244.5993 USD |
| Sale | 200 | 245.2300 USD |
| Sale | 214 | 244.8272 USD |
| Sale | 300 | 247.2800 USD |
| Sale | 300 | 246.9600 USD |
| Sale | 457 | 247.6170 USD |
| Sale | 470 | 248.1297 USD |
| Sale | 897 | 246.9323 USD |
| Sale | 1,200 | 246.3859 USD |
| Sale | 1,296 | 245.4231 USD |
| Sale | 1,880 | 245.2999 USD |
| Sale | 2,190 | 245.6707 USD |
| Sale | 2,418 | 246.3665 USD |
| Sale | 2,765 | 247.2552 USD |
| Sale | 2,800 | 246.3232 USD |
| Sale | 4,503 | 246.5882 USD |
| Sale | 5,413 | 246.4362 USD |
| Sale | 6,057 | 248.1300 USD |
| Sale | 12,108 | 246.6549 USD |
| Sale | 13,207 | 246.0479 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 30 Apr 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | |
|
| to which the option |
| ||
|
| or derivative |
| ||
|
| relates |
| ||
Put Options | Purchased | -100 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 100 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 6,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -6,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210430005355/en/
Copyright Business Wire 2021
Related Shares:
Barclays